REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

17/09/2019 17:50

RNS Number : 6785M
GlaxoSmithKline PLC
17 September 2019
 


 



1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr D Jackson   




b)


Position/status


PCA of Ms S Jackson (SVP, Global Communications and CEO Office)




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
 




b)


Nature of the transaction


Award of Ordinary Shares under the Company's Share Value Plan




c)


Price(s) and volume(s)






Price(s)


Volume(s)












£17.434


6,330


























d)


Aggregated information
 
 


N/A




Aggregated volume Price








e)


Date of the transaction


2019-09-03




f)


Place of the transaction
 


London Stock Exchange (XLON)



 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQDLFFKKFXBBK